Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]

Core Viewpoint - Xiantan Co., Ltd. reported significant growth in chicken product sales for January 2026, indicating strong performance in both poultry farming and food processing sectors [1] Company Summary - Xiantan Co., Ltd. achieved chicken product sales revenue of 546 million yuan and sales volume of 55,900 tons in January 2026, representing year-on-year changes of 54.90% and 44.89%, respectively [1] - The poultry farming and processing sector contributed 484 million yuan in sales revenue and 51,800 tons in sales volume, with year-on-year changes of 52.02% and 43.28% [1] - The food processing sector generated sales revenue of 61.99 million yuan and sales volume of 4,100 tons, showing year-on-year changes of 81.69% and 69.09% [1] Industry Summary - The poultry farming and processing industry experienced a revenue increase of 52.02% year-on-year, while the food processing industry saw an even higher growth rate of 81.69% [1] - The sequential changes in sales revenue for the poultry farming sector were 2.46%, and for the food processing sector, it was 7.52% [1] - Overall, the industry reflects a robust demand for chicken products, contributing to the positive financial performance of Xiantan Co., Ltd. [1]

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

Core Viewpoint - Xiantan Co., Ltd. reported a significant increase in chicken product sales revenue and volume for January 2026, indicating strong growth in the poultry industry [1] Group 1: Financial Performance - The company achieved chicken product sales revenue of 546 million yuan in January 2026, representing a year-on-year increase of 54.90% [1] - The sales volume reached 55,900 tons, showing a year-on-year growth of 44.89% [1] - On a month-on-month basis, sales revenue increased by 3.01% and sales volume by 1.49% [1]

董事和高级管理人员离职管理制度 第一章 总 则 第一条 为规范山东仙坛集团股份有限公司（以下简称"公司"）董事和高 级管理人员离职管理，保证公司健康、稳定、持续的发展，根据《中华人民共和 国公司法》（以下简称"《公司法》"）《中华人民共和国证券法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》等有关法律法规、规范性文件的规定，结合《山东仙坛集团 股份有限公司章程》（以下简称"《公司章程》"）和公司的实际情况，制定本 制度。 第二条 本制度适用于公司全体董事（含独立董事）及高级管理人员的离职 管理，包括但不限于任期届满、主动辞任、被解除职务、任期届满未连任或其他 原因离职的情形。 第二章 离职情形与程序 第三条 公司董事、高级管理人员可以在任期届满以前辞任或辞职，董事辞 任、高级管理人员辞职应当向公司提交书面辞职报告，报告中应说明辞任或辞职 原因。董事辞任的，自董事会收到辞职报告之日起辞任生效；高级管理人员辞职 的，自公司收到辞职报告之日起辞职生效，高级管理人员与公司之间的劳动或劳 务合同另有约定的除外。 山东仙坛集团股份有限公司 董事和高级管理人员离 ...

山东仙坛集团股份有限公司 总裁工作细则 山东仙坛集团股份有限公司 （一）《公司法》第一百七十八条规定情形的人员，被国务院证券监督管理机构确定为市 场禁入者，并且禁入尚未解除的人员，以及被国务院证券监督管理机构或证券交易所认定不适 宜担任上市公司总裁的人员，不得担任本公司的总裁； （二）具有较丰富的经济理论知识、管理知识及实践经验，具有较强的经济管理能力、决 策能力和行政执行能力； 总裁工作细则 第一章 总则 第一条 为进一步完善法人治理结构，提高议事和办事效率，规范山东仙坛集团股份有限 公司（以下简称"公司"）总裁等高级管理人员的行为，根据《中华人民共和国公司法》、《上 市公司治理准则》等有关法律法规、规范性文件的规定，结合《山东仙坛集团股份有限公司章 程》（以下简称"《公司章程》"）和公司的实际情况，制定本细则。 第二条 本细则规定了公司总裁等高级管理人员的责任，总裁、副总裁的职权及分工，总 裁办公会等内容。 第二章 总裁的任职资格和任免程序 第三条 公司设总裁一名，由董事长提名，董事会聘任或解聘。公司设副总裁、财务总监 等高级管理人员，由总裁提名，董事会聘任或解聘。 董事可以兼任总裁、副总裁或其他高级管理 ...

山东仙坛集团股份有限公司 董事和高级管理人员薪酬管理制度 山东仙坛集团股份有限公司 董事和高级管理人员薪酬管理制度 第一章 总 则 第一条 为规范山东仙坛集团股份有限公司（以下简称"公司"）董事和高 级管理人员薪酬管理，建立和完善科学有效的激励和约束机制，充分调动公司董 事和高级管理人员的工作积极性，提高公司的经营管理效益，根据《中华人民共 和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等有关 法律法规、规范性文件的规定，结合《山东仙坛集团股份有限公司章程》（以下 简称"《公司章程》"）和公司的实际情况，制定本制度。 第二条 本制度适用于公司全体董事及《公司章程》规定的高级管理人员。 第三条 公司董事和高级管理人员薪酬管理制度遵循以下原则： （一）公平性原则。薪酬分配兼顾责任、风险与收益，确保薪酬水平与董事、 高管承担的职责和贡献相适应，程序公开透明。 （二）竞争性原则。对标外部市场，参考市场薪酬水平，合理确定董事、高 管的薪酬水平，建立在行业内具有竞争力的薪酬体系。 山东仙坛集团股份有限公司 董事和高级管理人员薪酬 ...

第二条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相关 规定召开股东会，保证股东能够依法行使权利。公司董事会应当切实履行职责， 认真、按时组织股东会。公司全体董事应当勤勉尽责，确保股东会正常召开和依 法行使职权。 山东仙坛集团股份有限公司 股东会议事规则 山东仙坛集团股份有限公司 股东会议事规则 第一章 总则 第一条 为维护山东仙坛集团股份有限公司（以下简称"公司"）及公司股 东的合法权益，明确股东会的议事程序，保证股东会依法行使职权，根据《中华 人民共和国公司法》（以下简称"《公司法》"） 《中华人民共和国证券法》 （以下简称"《证券法》"）《上市公司股东会规则》《深圳证券交易所股票上 市规则》等有关法律法规、规范性文件的规定，结合《山东仙坛集团股份有限公 司章程》（以下简称"《公司章程》"）和公司实际情况，制定本规则。 (三) 单独或者合计持有公司百分之十以上股份（含表决权恢复的优先股等） 的股东请求时； (四) 董事会认为必要时； (五) 审计委员会提议召开时； (六) 法律、行政法规、部门规章或者《公司章程》规定的其他情形。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权 ...

山东仙坛集团股份有限公司章程 山东仙坛集团股份有限公司 章 程 二〇二六年二月 1 山东仙坛集团股份有限公司章程 山东仙坛集团股份有限公司章程 目 录 2 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东会 第一节 股东的一般规定 第二节 控股股东和实际控制人 第三节 股东会的一般规定 第四节 股东会的召集 第五节 股东会的提案与通知 第六节 股东会的召开 第七节 股东会的表决和决议 第五章 董事和董事会 第一节 董事的一般规定 第二节 董事会 第三节 独立董事 第四节 董事会专门委员会 第六章 高级管理人员 第七章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 山东仙坛集团股份有限公司章程 第八章 通知与公告 3 第一节 通知 第二节 公告 第九章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十章 修改章程 第十一章 附则 山东仙坛集团股份有限公司章程 第一章 总则 第一条 为维护山东仙坛集团股份有限公司（以下简称"公司"）、股 ...

山东仙坛集团股份有限公司 董事会议事规则 山东仙坛集团股份有限公司 董事会议事规则 第一章 总则 第一条 为了进一步规范山东仙坛集团股份有限公司（以下简称"公司"）董事会的议事 方式和决策程序，促使董事和董事会有效地履行其职责，提高董事会规范运作和科学决策水平， 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国证券法》《上 市公司章程指引》《上市公司治理准则》《上市公司独立董事管理办法》《深圳证券交易所股 票上市规则》（以下简称"《上市规则》"）《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等有关法律法规、规范性文件的规定，结合《山东仙坛集团股 份有限公司章程》（以下简称"《公司章程》"）和公司的实际情况，制订本规则。 （三）决定公司的经营计划和投资方案； （四）制订公司的利润分配方案和弥补亏损方案； （五）制订公司增加或者减少注册资本、发行债券或者其他证券及上市方案； 第二章 董事会组成及职权 第二条 公司设董事会，对股东会负责。 第三条 董事会由九名董事组成，其中独立董事三人，职工董事一人。 董事会设董事长一人，副董事长二人。 第四条 董事会行使下列职权： ...